MAP2K7 and melanoma: To identify downstream effectors of the PI3K and MAPK pathways, we used the BRAFV600E mutant human melanoma cell lines A2058 and 624MEL in which both pathways are activated, and thus the combination of PI3K and MEK inhibitors maximally reduces their activity and induces cell death (supplemental Fig. S1).